Titlebook: Ovarian Cancer; State of the Art and George Coukos,Andrew Berchuck,Robert Ozols Conference proceedings 2008 The Editor(s) (if applicable) a

tornado

書目名稱Ovarian Cancer影響因子(影響力)




書目名稱Ovarian Cancer影響因子(影響力)學(xué)科排名




書目名稱Ovarian Cancer網(wǎng)絡(luò)公開度




書目名稱Ovarian Cancer網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Ovarian Cancer被引頻次




書目名稱Ovarian Cancer被引頻次學(xué)科排名




書目名稱Ovarian Cancer年度引用




書目名稱Ovarian Cancer年度引用學(xué)科排名




書目名稱Ovarian Cancer讀者反饋




書目名稱Ovarian Cancer讀者反饋學(xué)科排名

流逝

Karen M. Hajra,Lijun Tan,J. Rebecca Liue book focusing on the understanding of Fluorescein angiogra.Fluorescein angiography is an indispensable tool in modern ophthalmology. It is founded on the evaluation of phenomena related to the behavior intravenously administered sodium fluorescein in the tissues of the ocular fundus..Commonly, tex

jeopardize

Bone-Scan

Fabian Benencia,George Coukose book focusing on the understanding of Fluorescein angiogra.Fluorescein angiography is an indispensable tool in modern ophthalmology. It is founded on the evaluation of phenomena related to the behavior intravenously administered sodium fluorescein in the tissues of the ocular fundus..Commonly, tex

連鎖,連串

爭論

Potential and Limitations in Early Diagnosis of Ovarian Cancer spread outside the ovaries, and about 90% when disease is confined to the ovaries. Ten-year survival for ovarian carcinoma varies greatly according to the stage at diagnosis (1) and survival is best when cancer is confined to the ovary at the time of diagnosis (Fig. 1); even patients with high-grad

Prophylaxis

PHIL

Classification of Ovarian Cancer: A Genomic Analysis due to the lack of reliable screening tools, the late stage of disease at the time of diagnosis, the high rate of recurrence of the disease, and the poor response to chemotherapy in the recurrent setting. Patients who present with stage I disease have over 90% 5-year survival, while those diagnosed

BOAST

Epigenetic Markers of Ovarian Cancerr is often asymptomatic in its early stages and because of lack of early detection strategies, most patients are diagnosed with disseminated disease, for whom the 5-year overall survival rate is only 20% (2). In the absence of an early detection test, improved therapies for advanced disease are crit

TIGER